pharmaceutical-business-review.com Report : Visit Site


  • Ranking Alexa Global: # 1,119,088

    Server:Microsoft-IIS/8.0, 1...
    X-Powered-By:ASP.NET

    The main IP address: 217.147.67.99,Your server United Kingdom,- ISP:Progressive Digital Media  TLD:com CountryCode:GB

    The description :pharmaceutical business review provides latest pharmaceutical industry news, analysis and market research reports.it also offers a comprehensive breakdown of pharmaceutical producers, contractors and ...

    This report updates in 21-Jun-2018

Created Date:2003-04-14
Changed Date:2017-03-09
Expires Date:2019-04-14

Technical data of the pharmaceutical-business-review.com


Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host pharmaceutical-business-review.com. Currently, hosted in United Kingdom and its service provider is Progressive Digital Media .

Latitude: 51.508529663086
Longitude: -0.12574000656605
Country: United Kingdom (GB)
City: -
Region: -
ISP: Progressive Digital Media

the related websites

HTTP Header Analysis


HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/8.0, 15_16 containing the details of what the browser wants and will accept back from the web server.

Transformer:SoundWave
Set-Cookie:BIGipServer~UK6-AG1-LBR01-PDM16LBR01~PHARMACEUTICAL-BUSINESS-REVIEW-POOL=rd13o00000000000000000000ffff0a54090fo80; path=/
Content-Encoding:gzip
Content-Type:text/html; charset=utf-8
Content-Length:16103
X-AspNet-Version:2.0.50727
Vary:Accept-Encoding
X-Powered-By:ASP.NET
Server:Microsoft-IIS/8.0, 15_16
Cache-Control:private
Date:Wed, 20 Jun 2018 20:19:22 GMT
X-AspNetMvc-Version:1.0

DNS

soa:ns.tmnplc.com. hostmaster.tmngroup.com. 2014091700 10800 3600 604800 600
ns:ns2.tmnplc.com.
ns3.tmngroup.com.
ns4.tmngroup.com.
ns.tmnplc.com.
ipv4:IP:217.147.67.99
ASN:15961
OWNER:ATTENDA-NET, GB
Country:DE

HtmlToText

-- jump to page content accessibility log in or register for enhanced features | forgotten password? or register for enhanced features-- white papers | suppliers | events | report store | companies | dining club | medical devices | videos production & manufacturing fine & speciality chemicals manufacturing process & production otc digital transformation intelligent edge enable digital optimise core -- drug research drug delivery drug discovery & development digital transformation intelligent edge enable digital optimise core -- contract research & services clinical trials contract research contract services digital transformation intelligent edge enable digital optimise core -- automation it & software laboratory instrumentation digital transformation intelligent edge enable digital optimise core -- inward investment packaging regulatory affairs digital transformation intelligent edge enable digital optimise core -- medical devices -- pharmaceutical business review all pharmaceutical business review return to: pbr home top headlines pharmaceutical business review -- can-fite delays phase 2 trial of liver cancer drug namodenoson israeli biotechnology company can-fite biopharma revealed that the results of its phase 2 trial of its liver cancer drug namodenoson (cf102) will be delayed longer than originally estimated. contract research & services > clinical trials > news alexion seeks approval from fda for pnh drug alxn1210 alexion pharmaceuticals said that it has submitted a biologics license application (bla) to the us food and drug administration (fda), seeking approval for its c5 complement inhibitor alxn1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria (pnh). production & manufacturing > process & production > news decibel therapeutics raises $55m in new funding round decibel therapeutics, a company focused on the discovery and development of medicines to treat hearing loss and hearing-related disorders, has raised $55m in a series c financing. drug research > drug discovery & development > news can-fite delays phase 2 trial of liver cancer drug namodenoson by pbr staff writer israeli biotechnology company can-fite biopharma revealed that the results of its phase 2 trial of its liver cancer drug namodenoson (cf102) will be delayed longer than originally estimated. contract research & services > clinical trials > news £56m medicines manufacturing innovation center to be established in scotland by pbr staff writer a new £56m medicines manufacturing innovation center (mmic) is to be established in renfrewshire, scotland, to offer businesses support to transform processes and technologies. drug research > drug discovery & development > news neurovive grants lhon therapy license to bridgebio pharma neurovive pharmaceutical has granted exclusive license of a subset of succinate prodrug chemistry under its nvp015 program to bridgebio pharma. drug research > drug discovery & development > news immunogen gets fda fast track status for mirvetuximab soravtansine to treat platinum-resistant ovarian cancer immunogen has secured fast track designation from the us food and drug administration (fda) for its lead program, mirvetuximab soravtansine. regulatory affairs > news latest news and insight by sector production & manufacturing alexion seeks approval from fda for pnh drug alxn1210 alexion pharmaceuticals said that it has submitted a biologics license application (bla) to the us food and drug administration (fda), seeking approval for its c5 complement inhibitor alxn1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria (pnh). production & manufacturing > process & production > news celltrion resubmits abla to fda for proposed trastuzumab biosimilar south korea-based celltrion said that it has completed a re-submission to the us food and drug administration (fda) seeking approval for ct-p6, a proposed mab biosimilar to cancer drug herceptin (trastuzumab). production & manufacturing > process & production > news drug research decibel therapeutics raises $55m in new funding round decibel therapeutics, a company focused on the discovery and development of medicines to treat hearing loss and hearing-related disorders, has raised $55m in a series c financing. drug research > drug discovery & development > news £56m medicines manufacturing innovation center to be established in scotland by pbr staff writer a new £56m medicines manufacturing innovation center (mmic) is to be established in renfrewshire, scotland, to offer businesses support to transform processes and technologies. drug research > drug discovery & development > news inward investment new wuxi life science to acquire wuxi pharmatech for $3.3bn shanghai-based wuxi pharmatech has entered into a merger agreement with new wuxi life science and its wholly owned subsidiary wuxi merger, worth a total cash consideration of $3.3bn. inward investment > news ppf group acquires minority stake in cytune pharma by pbr staff writer ppf group, in cooperation with sotio has completed acquisition of minority stake in french biotechnology firm cytune pharma. inward investment > news packaging catalent completes acquisition of australia's pharmapak by pbr staff writer us-based catalent pharma solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of pharmapak technologies, an australian pharmaceutical packaging business. production & manufacturing > otc > news mp global products introduces foam-free packaging for shipment of temperature sensitive pharmaceuticals mp global thermal packaging products insulated protective mailers and box liners are specifically designed for temperature control and protection of mail order shipments of temperature sensitive pharma, pet meds, and natural and organic cosmetics. packaging > news contract research & services can-fite delays phase 2 trial of liver cancer drug namodenoson by pbr staff writer israeli biotechnology company can-fite biopharma revealed that the results of its phase 2 trial of its liver cancer drug namodenoson (cf102) will be delayed longer than originally estimated. contract research & services > clinical trials > news x4p-001-rd demonstrates promising activity in whim syndrome patients by pbr staff writer x4 pharmaceuticals said that its x4p-001-rd has demonstrated promising activity in the ongoing open-label phase 2 portion of a phase 2/3 study in patients with whim syndrome. contract research & services > clinical trials > news automation horizon discovery out-licenses cell line engineering technology to us firm horizon discovery group has entered into a non-exclusive out-licensing agreement with an undisclosed us-based immuno-oncology company (the partner) for its technologies to support the development and manufacture of a biomanufacturing cell line for commercial use. automation > it & software > news ge to provide biomanufacturing platform for clover’s chinese facility by pbr staff writer ge healthcare will provide its biomanufacturing platform for clover biopharmaceuticals’ new production facility in china. automation > it & software > news regulatory affairs immunogen gets fda fast track status for mirvetuximab soravtansine to treat platinum-resistant ovarian cancer immunogen has secured fast track designation from the us food and drug administration (fda) for its lead program, mirvetuximab soravtansine. regulatory affairs > news fda approves roche's avastin plus chemotherapy for ovarian cancer after surgery the us food and drug administration (fda) has approved roche’s avastin (bevacizumab) plus chemotherapy (carboplatin and paclitaxel), followed by avastin as a single agent, for treating women with stage iii or iv ovarian cancer following initial surgical

URL analysis for pharmaceutical-business-review.com


http://www.pharmaceutical-business-review.com///suppliers/a-z/l
http://www.pharmaceutical-business-review.com/suppliers/persistence-market-research/news/global-scar-treatment-market-to-be-worth-us-126071-mn-by-2024-dermal-filling-laser-treatments-and-wrinkle-reduction-among-scar-treatments-witnessing-increased-demand-says-pmr-31273
http://www.pharmaceutical-business-review.com///accessibility
http://www.pharmaceutical-business-review.com/
http://www.pharmaceutical-business-review.com
http://www.pharmaceutical-business-review.com /contract-research-and-services
http://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions
http://www.pharmaceutical-business-review.com///events
http://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/nsf-asks-why-annex-1-is-important-to-you
http://www.pharmaceutical-business-review.com///whitepapers
http://www.pharmaceutical-business-review.com//#content
http://www.pharmaceutical-business-review.com///suppliers/a-z/c
http://www.pharmaceutical-business-review.com///suppliers/a-z/v
http://www.pharmaceutical-business-review.com/sitemap
http://www.pharmaceutical-business-review.com/videos
data-label.co.uk

Whois Information


Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: PHARMACEUTICAL-BUSINESS-REVIEW.COM
Registry Domain ID: 96790032_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.lcn.com
Registrar URL: https://www.lcn.com
Updated Date: 2017-07-06T09:42:04+01:00
Creation Date: 2003-04-14T05:09:49+01:00
Registrar Registration Expiration Date: 2019-04-14T09:09:49+01:00
Registrar: LCN.com Ltd
Registrar IANA ID: 602
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +44.1438342490
Domain Status: clientDeleteProhibited
Domain Status: clientTransferProhibited
Domain Status: clientUpdateProhibited
Registry Registrant ID:
Registrant Name: PDMG Plc IT Department
Registrant Organisation: Progressive Digital Media Group Plc
Registrant Street: Progressive House
Registrant Street: 2 Maidstone Road
Registrant City: Foots Cray, Sidcup
Registrant State: Kent
Registrant Postal Code: DA14 5HZ
Registrant Country: GB
Registrant Phone: +44.2082697700
Registrant Email: [email protected]
Registry Admin ID: AI-727110
Admin Name: PDMG Plc IT Department
Admin Organisation: Progressive Digital Media Group Plc
Admin Street: Progressive House
Admin Street: 2 Maidstone Road
Admin City: Foots Cray, Sidcup
Admin State: Kent
Admin Postal Code: DA14 5HZ
Admin Country: GB
Admin Phone: +44.2082697700
Admin Email: [email protected]
Registry Tech ID: AI-300624
Tech Name: LCN Hostmaster
Tech Organization: LCN.com Ltd
Tech Street: Units H, J, K, Gateway 1000, Whittle Way
Tech City: Stevenage
Tech State/Province: Herts
Tech Postal Code: SG1 2FP
Tech Country: GB
Tech Phone: +44.1438342490
Tech Fax: +44.1438300137
Tech Email: [email protected]
Name Server: ns.tmnplc.com
Name Server: ns2.tmnplc.com
Name Server: ns3.tmngroup.com
Name Server: ns4.tmngroup.com
DNSSec: Unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-07-06T09:42:04+01:00 <<<

Domain Registration Service Provided By: LCN.com

The data in LCN.com's WHOIS database is provided by LCN.com for information
purposes, and to assist persons in obtaining information about or related to a
domain name registration record. LCN.com does not guarantee its accuracy.

By submitting a WHOIS query, you agree that you will use the data obtained only
for lawful purposes and that, under no circumstances will you use this data to:

(a) allow, enable, or otherwise support the transmission by e-mail, telephone,
or facsimile of mass, unsolicited, commercial advertising or solicitations to
entities other than the data recipient's own existing customers; or (b) enable
high volume, automated, electronic processes that send queries or data to the
systems of LCN.com, except as reasonably necessary to register domain names or
modify existing registrations.

By submitting this query, you agree to abide by this policy.

LCN.com reserves the right to modify these terms at any time.


*******************************************************************************
*******************************************************************************
** **
** Domain Registration Service Provided By: LCN.com **
** ------------------------------------------------ **
** **
** **
** - For award winning domain name services visit: **
** **
** https://www.lcn.com/domain_names **
** **
** - For powerful & reliable web hosting backed by a 30 day money **
** backed guarantee visit: **
** **
** https://www.lcn.com/web_hosting **
** **
** - For support visit: **
** **
** https://www.lcn.com/contact_us **
** **
*******************************************************************************
*******************************************************************************

  REGISTRAR LCN.COM LTD.

  REFERRER http://www.LCN.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =pharmaceutical-business-review.com

  PORT 43

  SERVER whois.lcn.com

  ARGS pharmaceutical-business-review.com

  PORT 43

  TYPE domain

DOMAIN

  NAME pharmaceutical-business-review.com

NSERVER

  NS.TMNPLC.COM 91.208.117.43

  NS2.TMNPLC.COM 91.208.117.43

  NS3.TMNGROUP.COM (DOES NOT EXIST)

  NS4.TMNGROUP.COM (DOES NOT EXIST)

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

  CHANGED 2017-03-09

  CREATED 2003-04-14

  EXPIRES 2019-04-14

  REGISTERED yes

Go to top

Mistakes


The following list shows you to spelling mistakes possible of the internet users for the website searched .

  • www.upharmaceutical-business-review.com
  • www.7pharmaceutical-business-review.com
  • www.hpharmaceutical-business-review.com
  • www.kpharmaceutical-business-review.com
  • www.jpharmaceutical-business-review.com
  • www.ipharmaceutical-business-review.com
  • www.8pharmaceutical-business-review.com
  • www.ypharmaceutical-business-review.com
  • www.pharmaceutical-business-reviewebc.com
  • www.pharmaceutical-business-reviewebc.com
  • www.pharmaceutical-business-review3bc.com
  • www.pharmaceutical-business-reviewwbc.com
  • www.pharmaceutical-business-reviewsbc.com
  • www.pharmaceutical-business-review#bc.com
  • www.pharmaceutical-business-reviewdbc.com
  • www.pharmaceutical-business-reviewfbc.com
  • www.pharmaceutical-business-review&bc.com
  • www.pharmaceutical-business-reviewrbc.com
  • www.urlw4ebc.com
  • www.pharmaceutical-business-review4bc.com
  • www.pharmaceutical-business-reviewc.com
  • www.pharmaceutical-business-reviewbc.com
  • www.pharmaceutical-business-reviewvc.com
  • www.pharmaceutical-business-reviewvbc.com
  • www.pharmaceutical-business-reviewvc.com
  • www.pharmaceutical-business-review c.com
  • www.pharmaceutical-business-review bc.com
  • www.pharmaceutical-business-review c.com
  • www.pharmaceutical-business-reviewgc.com
  • www.pharmaceutical-business-reviewgbc.com
  • www.pharmaceutical-business-reviewgc.com
  • www.pharmaceutical-business-reviewjc.com
  • www.pharmaceutical-business-reviewjbc.com
  • www.pharmaceutical-business-reviewjc.com
  • www.pharmaceutical-business-reviewnc.com
  • www.pharmaceutical-business-reviewnbc.com
  • www.pharmaceutical-business-reviewnc.com
  • www.pharmaceutical-business-reviewhc.com
  • www.pharmaceutical-business-reviewhbc.com
  • www.pharmaceutical-business-reviewhc.com
  • www.pharmaceutical-business-review.com
  • www.pharmaceutical-business-reviewc.com
  • www.pharmaceutical-business-reviewx.com
  • www.pharmaceutical-business-reviewxc.com
  • www.pharmaceutical-business-reviewx.com
  • www.pharmaceutical-business-reviewf.com
  • www.pharmaceutical-business-reviewfc.com
  • www.pharmaceutical-business-reviewf.com
  • www.pharmaceutical-business-reviewv.com
  • www.pharmaceutical-business-reviewvc.com
  • www.pharmaceutical-business-reviewv.com
  • www.pharmaceutical-business-reviewd.com
  • www.pharmaceutical-business-reviewdc.com
  • www.pharmaceutical-business-reviewd.com
  • www.pharmaceutical-business-reviewcb.com
  • www.pharmaceutical-business-reviewcom
  • www.pharmaceutical-business-review..com
  • www.pharmaceutical-business-review/com
  • www.pharmaceutical-business-review/.com
  • www.pharmaceutical-business-review./com
  • www.pharmaceutical-business-reviewncom
  • www.pharmaceutical-business-reviewn.com
  • www.pharmaceutical-business-review.ncom
  • www.pharmaceutical-business-review;com
  • www.pharmaceutical-business-review;.com
  • www.pharmaceutical-business-review.;com
  • www.pharmaceutical-business-reviewlcom
  • www.pharmaceutical-business-reviewl.com
  • www.pharmaceutical-business-review.lcom
  • www.pharmaceutical-business-review com
  • www.pharmaceutical-business-review .com
  • www.pharmaceutical-business-review. com
  • www.pharmaceutical-business-review,com
  • www.pharmaceutical-business-review,.com
  • www.pharmaceutical-business-review.,com
  • www.pharmaceutical-business-reviewmcom
  • www.pharmaceutical-business-reviewm.com
  • www.pharmaceutical-business-review.mcom
  • www.pharmaceutical-business-review.ccom
  • www.pharmaceutical-business-review.om
  • www.pharmaceutical-business-review.ccom
  • www.pharmaceutical-business-review.xom
  • www.pharmaceutical-business-review.xcom
  • www.pharmaceutical-business-review.cxom
  • www.pharmaceutical-business-review.fom
  • www.pharmaceutical-business-review.fcom
  • www.pharmaceutical-business-review.cfom
  • www.pharmaceutical-business-review.vom
  • www.pharmaceutical-business-review.vcom
  • www.pharmaceutical-business-review.cvom
  • www.pharmaceutical-business-review.dom
  • www.pharmaceutical-business-review.dcom
  • www.pharmaceutical-business-review.cdom
  • www.pharmaceutical-business-reviewc.om
  • www.pharmaceutical-business-review.cm
  • www.pharmaceutical-business-review.coom
  • www.pharmaceutical-business-review.cpm
  • www.pharmaceutical-business-review.cpom
  • www.pharmaceutical-business-review.copm
  • www.pharmaceutical-business-review.cim
  • www.pharmaceutical-business-review.ciom
  • www.pharmaceutical-business-review.coim
  • www.pharmaceutical-business-review.ckm
  • www.pharmaceutical-business-review.ckom
  • www.pharmaceutical-business-review.cokm
  • www.pharmaceutical-business-review.clm
  • www.pharmaceutical-business-review.clom
  • www.pharmaceutical-business-review.colm
  • www.pharmaceutical-business-review.c0m
  • www.pharmaceutical-business-review.c0om
  • www.pharmaceutical-business-review.co0m
  • www.pharmaceutical-business-review.c:m
  • www.pharmaceutical-business-review.c:om
  • www.pharmaceutical-business-review.co:m
  • www.pharmaceutical-business-review.c9m
  • www.pharmaceutical-business-review.c9om
  • www.pharmaceutical-business-review.co9m
  • www.pharmaceutical-business-review.ocm
  • www.pharmaceutical-business-review.co
  • pharmaceutical-business-review.comm
  • www.pharmaceutical-business-review.con
  • www.pharmaceutical-business-review.conm
  • pharmaceutical-business-review.comn
  • www.pharmaceutical-business-review.col
  • www.pharmaceutical-business-review.colm
  • pharmaceutical-business-review.coml
  • www.pharmaceutical-business-review.co
  • www.pharmaceutical-business-review.co m
  • pharmaceutical-business-review.com
  • www.pharmaceutical-business-review.cok
  • www.pharmaceutical-business-review.cokm
  • pharmaceutical-business-review.comk
  • www.pharmaceutical-business-review.co,
  • www.pharmaceutical-business-review.co,m
  • pharmaceutical-business-review.com,
  • www.pharmaceutical-business-review.coj
  • www.pharmaceutical-business-review.cojm
  • pharmaceutical-business-review.comj
  • www.pharmaceutical-business-review.cmo
Show All Mistakes Hide All Mistakes